HARBIN , January 23 , SinoCast -- Harbin Pharmaceutical Group Co., Ltd. (SHSE: 600664) predicted net profit attributable to shareholders in 2013 to decline 60% to 70% from a year earlier, when the figure reached CNY 499.65 million .
Most Popular Stories
- Obama Administration Releases Proposal to Regulate For-Profit Colleges
- Elizabeth Vargas' Husband Marc Cohn Addresses Rumors
- Keurig Adds Peet's coffee, Alters Starbucks deal
- Quiznos Files for Chapter 11
- U.S. to Relinquish Gov't Control Over Internet
- SoCalGas Reaches Record Spend on Diversity Suppliers
- U.S. Consumer Sentiment Falls in Early March
- Is Malaysian Airlines Flight 370 in Andaman Sea?
- Vybz Kartel Convicted of Murder
- Koch Brothers Step up Anti-Obamacare Campaign